For research use only. Not for therapeutic Use.
GL516（Cat No.:I028058）is a small molecule compound that has been studied for its potential therapeutic applications, particularly in the treatment of cancer and autoimmune diseases. It works by targeting specific enzymes or signaling pathways involved in cell growth, survival, and immune regulation. GL516 has demonstrated promise in preclinical studies by inhibiting tumor growth and modulating immune responses, potentially enhancing the effectiveness of other cancer treatments. However, further research and clinical trials are needed to assess its safety, pharmacokinetics, and therapeutic efficacy before it can be considered for widespread clinical use.
| Catalog Number | I028058 |
| Synonyms | GL516 |
| Molecular Formula | C23H22O5 |
| Purity | 98% |
| Solubility | Soluble in DMSO |
| Appearance | Solid powder |
| Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| IUPAC Name | 2-methyl-2-[4-[(4-phenoxyphenoxy)methyl]phenoxy]propanoic acid |
| InChI | InChI=1S/C23H22O5/c1-23(2,22(24)25)28-21-10-8-17(9-11-21)16-26-18-12-14-20(15-13-18)27-19-6-4-3-5-7-19/h3-15H,16H2,1-2H3,(H,24,25) |
| InChIKey | XKRVKDITBMJKRZ-UHFFFAOYSA-N |
| SMILES | CC(C)(C(=O)O)OC1=CC=C(C=C1)COC2=CC=C(C=C2)OC3=CC=CC=C3 |
